US 7846907
Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene
granted A61KA61K38/00A61P
Quick answer
US patent 7846907 (Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00, A61P, A61P35/00